The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4

Combretastatin A-4 (CA4) is the lead compound of a relatively new class of vascular disrupting agents that target existing tumor blood vessels. Recent studies showed the CA4 might inhibit angiogenesis. However, the underlying molecular mechanisms by which CA4 exerts its anti-angiogenic effects are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Min, Huang, Jingjia, Liu, Suyou, Xiao, Yuhang, Qin, Xiyuan, Liu, Jia, Pi, Chaoqiong, Luo, Tiao, Li, Jijia, Chen, Xianghui, Luo, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919637/
https://www.ncbi.nlm.nih.gov/pubmed/27338725
http://dx.doi.org/10.1038/srep28139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919637/
https://www.ncbi.nlm.nih.gov/pubmed/27338725
http://dx.doi.org/10.1038/srep28139

Ejemplares similares